Filing Details

Accession Number:
0001144204-14-069746
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-19 16:06:34
Reporting Period:
2014-11-17
Filing Date:
2014-11-19
Accepted Time:
2014-11-19 16:06:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419701 L.p. Partners Venture Longitude C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
No No Yes No
1430719 Longitude Capital Associates, L.p. C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
No No Yes No
1430720 Longitude Capital Partners, Llc 800 El Camino Real, Suite 220
Menlo Park CA 94025
No No Yes No
1431159 Juliet Bakker Tammenoms C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-17 200,591 $32.01 1,683,178 No 4 S Indirect By LVP
Common Stock Disposition 2014-11-17 136,148 $32.93 1,547,030 No 4 S Indirect By LVP
Common Stock Disposition 2014-11-17 135,816 $33.79 1,411,214 No 4 S Indirect By LVP
Common Stock Disposition 2014-11-17 4,021 $32.01 33,736 No 4 S Indirect By LCA
Common Stock Disposition 2014-11-17 2,728 $32.93 31,008 No 4 S Indirect By LCA
Common Stock Disposition 2014-11-17 2,722 $33.79 28,286 No 4 S Indirect By LCA
Common Stock Disposition 2014-11-18 4,592 $31.56 1,406,622 No 4 S Indirect By LVP
Common Stock Disposition 2014-11-18 412 $32.14 1,406,210 No 4 S Indirect By LVP
Common Stock Disposition 2014-11-18 92 $31.57 28,194 No 4 S Indirect By LCA
Common Stock Disposition 2014-11-18 8 $32.13 28,186 No 4 S Indirect By LCA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LVP
No 4 S Indirect By LVP
No 4 S Indirect By LVP
No 4 S Indirect By LCA
No 4 S Indirect By LCA
No 4 S Indirect By LCA
No 4 S Indirect By LVP
No 4 S Indirect By LVP
No 4 S Indirect By LCA
No 4 S Indirect By LCA
Footnotes
  1. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $31.52 to $32.51. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  2. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $32.52 to $33.5150. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $33.52 to $34.42. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $31.52 to $32.51. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  5. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $32.52 to $33.5150. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  6. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $33.52 to $34.42. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  7. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $31.08 to $32.01. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  8. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $32.09 to $32.26. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  9. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $31.08 to $32.01. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  10. Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $32.09 to $32.26. The price reported reflects the weighted average sale price. Each Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  11. This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA") and Juliet Tammenoms Bakker ("Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP, as the general partner of each of LVP and LCA, has the power to vote and dispose of securities held by each of them. Patrick G. Enright, who serves on the Board of Directors of the Issuer and files separate Section 16 reports relating to the Issuer, and Bakker are each managing members of LCP and, as such, may be deemed to beneficially own the shares held by LVP and LCA. Each of LCP and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.